Project: Super Biased Ligands for Treatment of Type II Diabetes

We have very exciting results showing that we can develop compounds, “super biased ligands”, that simultaneously stimulate glucose uptake in muscle and brown fat through a novel insulin independent signalling pathway. The compounds radically reduce blood glucose levels in rodent diabetes models and our goal is to develop them to a preCD for the treatment of type 2 diabetes and forge a business alliance with a pharmaceutical company.

Acronym SUBERB (Reference Number: 10635)
Duration 01/09/2016 - 01/09/2019
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 5

Project partner

Number Name Role Country
24745 Atrogi AB Coordinator Sweden
24746 Maastricht University Partner Netherlands
24747 Stockholms Universitet Partner Sweden
24748 Latvia Institute for Organic Synthesis Partner Latvia